Radiographic External Measurement Technique for TIVAP Placement
Accuracy and Clinical Applicability of a Chest X-Ray-Based External Measurement Method for Optimal Catheter Tip Positioning in Totally Implantable Venous Access Port Placement
1 other identifier
interventional
120
1 country
1
Brief Summary
Totally implantable venous access ports (TIVAPs) are commonly used in patients who need long-term intravenous treatment such as chemotherapy, parenteral nutrition, or repeated blood sampling. Correct placement of the catheter tip is important to reduce the risk of complications, including arrhythmia, thrombosis, catheter dysfunction, vessel injury, and infection. Several methods are used to determine catheter tip position during port placement, including fluoroscopy, echocardiography, and chest X-ray. However, some of these methods may require additional equipment, increase procedure time, or may not be available in all hospitals. This study aims to evaluate a simple chest X-ray-based external measurement method to estimate the appropriate catheter length before TIVAP placement. In this method, anatomical landmarks identified on a recent chest X-ray are used to calculate the expected catheter length, which is then applied during the procedure. The main goal of the study is to assess how accurately this method places the catheter tip in the desired anatomical position. Secondary goals include evaluating the rate of optimal tip placement, procedure-related complications, and the relationship between predicted and actual catheter tip positions. If successful, this method may provide a practical, low-cost, and widely applicable technique to improve TIVAP placement in routine clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2026
CompletedStudy Start
First participant enrolled
April 22, 2026
CompletedFirst Posted
Study publicly available on registry
April 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 15, 2026
April 30, 2026
April 1, 2026
2 months
April 18, 2026
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of Optimal Catheter Tip Positioning
Proportion of participants with the catheter tip located at the cavoatrial junction or within 1-2 cm proximal to this level on post-procedure chest X-ray.
Immediately after port implantation (within 24 hours)
Study Arms (1)
Chest X-Ray-Based External Measurement Group
EXPERIMENTALParticipants in this arm undergo totally implantable venous access port placement using a chest X-ray-based external measurement method to determine catheter length before implantation. Anatomical landmarks identified on a recent chest X-ray are used to estimate the target catheter length. Post-procedure chest X-ray is performed to assess final catheter tip position and procedural outcomes.
Interventions
A pre-procedural measurement technique used during totally implantable venous access port placement. Anatomical landmarks identified on a recent posterior-anterior chest X-ray are used to estimate the appropriate catheter length before implantation in order to optimize final catheter tip position.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Scheduled for elective totally implantable venous access port placement
- Available posterior-anterior chest X-ray obtained within the previous 3 months
- Ability to provide written informed consent
You may not qualify if:
- Known central venous stenosis or occlusion due to previous central venous catheter or port history
- Congenital heart disease
- Significant mediastinal anatomical abnormality or distortion
- Chest X-ray in which anatomical landmarks cannot be clearly identified
- Emergency port implantation
- Pregnancy (if required by local ethics policy)
- Refusal or inability to provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SBU Bagcilar Education and Training Hospital
Istanbul, ABD Dışında, 34400, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Department of Anesthesiology and Reanimation
Study Record Dates
First Submitted
April 18, 2026
First Posted
April 23, 2026
Study Start
April 22, 2026
Primary Completion (Estimated)
June 15, 2026
Study Completion (Estimated)
August 15, 2026
Last Updated
April 30, 2026
Record last verified: 2026-04